B
grade
Emerging pharmacotherapies for androgenetic alopecia.
ABS-201 · Expert opinion on pharmacotherapy · 2026 · Review
Confirms ABS-201 is in clinical development for androgenetic alopecia as a prolactin-receptor-targeting biologic. It contains no data on whether it works.